These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17485787)

  • 1. Advances in antiretroviral therapy.
    Jones J; Taylor B; Wilkin TJ; Hammer SM
    Top HIV Med; 2007; 15(2):48-82. PubMed ID: 17485787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy.
    Wilkin TJ; Taylor B; Olender S; Hammer SM
    Top HIV Med; 2008; 16(1):31-60. PubMed ID: 18441381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in antiretroviral therapy.
    Wilkin TJ; Taylor B; Olender S; Hammer SM
    Top HIV Med; 2009; 17(2):68-88. PubMed ID: 19401609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel targets for antiretroviral therapy: clinical progress to date.
    Dau B; Holodniy M
    Drugs; 2009; 69(1):31-50. PubMed ID: 19192935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raltegravir: the first HIV type 1 integrase inhibitor.
    Hicks C; Gulick RM
    Clin Infect Dis; 2009 Apr; 48(7):931-9. PubMed ID: 19231980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in HIV drug resistance.
    Cane PA
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral salvage therapy for multiclass drug-resistant HIV-1-infected patients: from clinical trials to daily clinical practice.
    Imaz A; Falcó V; Ribera E
    AIDS Rev; 2011; 13(3):180-93. PubMed ID: 21799536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raltegravir: the first HIV integrase inhibitor.
    Cocohoba J; Dong BJ
    Clin Ther; 2008 Oct; 30(10):1747-65. PubMed ID: 19014832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in antiretroviral therapy.
    Sobieszczyk ME; Jones J; Wilkin T; Hammer SM
    Top HIV Med; 2006; 14(1):36-62. PubMed ID: 16641526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.
    Sierra-Aragón S; Walter H
    Intervirology; 2012; 55(2):84-97. PubMed ID: 22286875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of raltegravir-containing regimens in antiretroviral-naïve and -experienced individuals in routine clinical practice.
    Jaeckle M; Khaykin P; Haberl A; De Leuw P; Schüttfort G; Stephan C; Wolf T
    Int J STD AIDS; 2016 Nov; 27(13):1170-1179. PubMed ID: 26429890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments.
    Menéndez-Arias L
    Antiviral Res; 2013 Apr; 98(1):93-120. PubMed ID: 23403210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium.
    Nguyen BY; Isaacs RD; Teppler H; Leavitt RY; Sklar P; Iwamoto M; Wenning LA; Miller MD; Chen J; Kemp R; Xu W; Fromtling RA; Vacca JP; Young SD; Rowley M; Lower MW; Gottesdiener KM; Hazuda DJ
    Ann N Y Acad Sci; 2011 Mar; 1222():83-9. PubMed ID: 21434946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in antiretroviral therapy.
    Sobieszczyk ME; Talley AK; Wilkin T; Hammer SM
    Top HIV Med; 2005; 13(1):24-44. PubMed ID: 15849370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in antiretroviral therapy.
    Wilkin TJ; Shalev N; Tieu HV; Hammer SM
    Top HIV Med; 2010; 18(2):66-92. PubMed ID: 20516526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management of HIV-1 resistance.
    Paredes R; Clotet B
    Antiviral Res; 2010 Jan; 85(1):245-65. PubMed ID: 19808056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program.
    Descamps D; Peytavin G; Visseaux B; Tubiana R; Damond F; Campa P; Charpentier C; Khuong-Josses MA; Duvivier C; Karmochkine M; Lukiana T; Matheron S
    Clin Infect Dis; 2015 May; 60(10):1521-7. PubMed ID: 25690598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop.
    Mascolini M; Boucher CA; Mellors JW; Larder BA; Richman DD
    Antivir Ther; 2009; 14(7):1015-37. PubMed ID: 19918107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Integrase inhibitors - new challenges for the treatment of HIV-1 infections].
    Stock I
    Med Monatsschr Pharm; 2013 Dec; 36(12):448-59; quiz 461-2. PubMed ID: 24450269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.